Concerning the CYP17 MspA1 polymorphism and breast cancer risk:: a meta-analysis

被引:13
作者
Feigelson, HS
McKean-Cowdin, R
Henderson, BE
机构
[1] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA
[2] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA
关键词
D O I
10.1093/mutage/17.5.445
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:445 / 446
页数:2
相关论文
共 10 条
[1]  
Bergman-Jungestrom M, 1999, INT J CANCER, V84, P350, DOI 10.1002/(SICI)1097-0215(19990820)84:4<350::AID-IJC3>3.0.CO
[2]  
2-L
[3]  
Feigelson HS, 2001, CANCER RES, V61, P785
[4]   CAN METAANALYSIS BE SALVAGED [J].
GREENLAND, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (09) :783-787
[5]  
Haiman CA, 1999, CANCER RES, V59, P1015
[6]  
Helzlsouer KJ, 1998, CANCER EPIDEM BIOMAR, V7, P945
[7]  
Kristensen VN, 1999, CANCER RES, V59, P2825
[8]  
Mitrunen K, 2000, CANCER EPIDEM BIOMAR, V9, P1343
[9]  
Weston A, 1998, CANCER EPIDEM BIOMAR, V7, P941
[10]   The CYP17 MspA1 polymorphism and breast cancer risk:: a meta-analysis [J].
Ye, Z ;
Parry, JM .
MUTAGENESIS, 2002, 17 (02) :119-126